Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.460
+0.230 (18.70%)
At close: Oct 17, 2025, 4:00 PM EDT
1.400
-0.060 (-4.11%)
After-hours: Oct 17, 2025, 7:59 PM EDT
Equillium Market Cap
Equillium has a market cap or net worth of $86.87 million as of October 17, 2025. Its market cap has increased by 190.91% in one year.
Market Cap
86.87M
Enterprise Value
75.64M
1-Year Change
190.91%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $86.87M, a decrease of -62.96%. That is a compound annual growth rate of -13.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 86.87M | 227.71% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | 132.29M | 125.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.68B |
| Johnson & Johnson | 461.41B |
| AbbVie | 401.13B |
| UnitedHealth Group | 327.07B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 224.14B |